Roth Capital Partners analyst Chip Moore says Amprius Technologies’ (Amprius Technologies, Stock Quote, Chart, News, Analysts, Financials NYSE:AMPX) new defence grant supports the company’s capital-light domestic capacity ramp. In a Sept. 28 update, Moore reiterated his “Buy” rating and US$22.00 target on Amprius. Amprius was awarded a U.S. Department of War grant of up to […]
Roth Capital Partners analyst Jonathan Aschoff says NeOnc Technologies Holdings’ (NeOnc Technologies Holdings Stock Quote, Chart, News, Analysts, Financials NYSE:NTHI) lead brain cancer assets could move into pivotal trials by year-end. In a Sept. 24 initiation report, Aschoff launched coverage of NeOnc with a “Buy” rating and US$20.00 target. NeOnc is a clinical-stage oncology company […]
Share
Tweet
Share
